Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03820817Phase 1Completed
Rifaximin in Patients With Monoclonal Gammopathy
Gammopathy IggGammopathy, MonoclonalIgA Monoclonal Gammopathy+6 more
PrincipalinvestigatorStart date: 2019-05-15
NCT01718899Phase 1Completed
Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Noopur Raje, MD

Massachusetts General Hospital

Related
6 trials

Shared therapeutic areas:

Smoldering Multiple Myeloma

Worked with same sponsors:

OncoPep, Inc.
Collaborated on 1 trial
Similarity Score14%

Michael Wang, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Smoldering Multiple Myeloma

Worked with same sponsors:

OncoPep, Inc.
Collaborated on 1 trial
Similarity Score14%

Mark J Roschewski, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Smoldering Multiple MyelomaWaldenstrom Macroglobulinemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Waldenstrom Macroglobulinemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

JS Kim, M.D, Ph.D

Severance Hospital, Yonsei University Health System

Related
1 trials

Shared therapeutic areas:

Waldenstrom Macroglobulinemia
Similarity Score3%

Steven P. Treon, MD, MA, PhD

Dana-Farber Cancer Institute

Related
4 trials

Shared therapeutic areas:

Waldenstrom Macroglobulinemia
Similarity Score3%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Waldenstrom Macroglobulinemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Tracy E Crane, Phd, RDN

University of Miami

Related
5 trials

Shared therapeutic areas:

Smoldering Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Waldenstrom Macroglobulinemia
Similarity Score3%

Evangelos Terpos, Prof

Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)

Related
5 trials

Shared therapeutic areas:

Gammopathy, Monoclonal
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03820817Phase 1PrincipalInvestigator

Rifaximin in Patients With Monoclonal Gammopathy

Gammopathy IggGammopathy, MonoclonalIgA Monoclonal Gammopathy+6 more
Completed
NCT01718899Phase 1PrincipalInvestigator

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Smoldering Multiple Myeloma
Completed

All 2 trials loaded